Author of the publication

Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria.

, , , , , , , , , , , , , , , , and . 123 (13): 2094--2101 (March 2014)
DOI: 10.1182/blood-2013-11-536573

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Novel mechanisms and functions of complement., , , , and . Nature Immunology, 18 (12): 1288--1298 (November 2017)Local complement-targeted intervention in periodontitis: proof-of-concept using a C5a receptor (CD88) antagonist., , , , , , and . Journal of Immunology, 189 (11): 5442--5448 (December 2012)Therapeutic C3 inhibitor Cp40 abrogates complement activation induced by modern hemodialysis filters., , , , , and . Immunobiology, 220 (4): 476--482 (April 2015)Complement component C3 - The "Swiss Army Knife" of innate immunity and host defense., , , , and . Immunol.Rev., 274 (1): 33--58 (November 2016)Rare loss-of-function mutation in complement component C3 provides insight into molecular and pathophysiological determinants of complement activity., , , , , , , , and . Journal of immunology (Baltimore, Md. : 1950), 194 (7): 3305--3316 (April 2015)The renaissance of complement therapeutics., , , and . Nature Reviews Nephrology, (December 2017)Pericytes and immune cells contribute to complement activation in tubulointerstitial fibrosis., , , , , , , , , and 2 other author(s). American journal of physiology. Renal physiology, 312 (3): F516--F532 (March 2017)High-Fat Diet-Induced Complement Activation Mediates Intestinal Inflammation and Neoplasia, Independent of Obesity., , , , , , , and . Molecular cancer research : MCR, 14 (10): 953--965 (October 2016)Compstatin Cp40 blocks hematin-mediated deposition of C3b fragments on erythrocytes: Implications for treatment of malarial anemia., , , , , , and . Clinical immunology (Orlando, Fla.), (October 2016)Complement C3-Targeted Therapy: Replacing Long-Held Assertions with Evidence-Based Discovery., , , , and . Trends in Immunology, 38 (6): 383--394 (June 2017)